Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Assets: 2014-2024

Historic Assets for Viking Therapeutics (VKTX) over the last 11 years, with Dec 2024 value amounting to $908.3 million.

  • Viking Therapeutics' Assets fell 21.16% to $739.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $739.4 million, marking a year-over-year decrease of 21.16%. This contributed to the annual value of $908.3 million for FY2024, which is 146.50% up from last year.
  • According to the latest figures from FY2024, Viking Therapeutics' Assets is $908.3 million, which was up 146.50% from $368.5 million recorded in FY2023.
  • Over the past 5 years, Viking Therapeutics' Assets peaked at $908.3 million during FY2024, and registered a low of $168.5 million during FY2022.
  • Over the past 3 years, Viking Therapeutics' median Assets value was $368.5 million (recorded in 2023), while the average stood at $481.8 million.
  • Per our database at Business Quant, Viking Therapeutics' Assets declined by 20.00% in 2022 and then soared by 146.50% in 2024.
  • Over the past 5 years, Viking Therapeutics' Assets (Yearly) stood at $256.5 million in 2020, then declined by 17.87% to $210.7 million in 2021, then decreased by 20.00% to $168.5 million in 2022, then soared by 118.65% to $368.5 million in 2023, then surged by 146.50% to $908.3 million in 2024.